SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
25-Sep-24 8:54 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 23-Sep-24 | Option Exercise | 2,000 | $52.27 | $104,540.00 | 9% 22.53K to 24.53K | |
25-Sep-24 8:54 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 23-Sep-24 | Option Sale | 2,000 | $99.60 | $199,201.00 | (8%) 24.53K to 22.53K | |
30-Aug-24 8:56 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Aug-24 | Option Exercise | 1,500 | $52.27 | $78,405.00 | 7% 22.53K to 24.03K | |
30-Aug-24 8:56 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Aug-24 | Option Sale | 1,500 | $106.39 | $159,591.00 | (6%) 24.03K to 22.53K | |
02-Jul-24 7:45 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Jun-24 | Acquisition (other) | 329 | $60.71 | $19,972.60 | 1% 22.2K to 22.53K | |
13-May-24 5:32 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 09-May-24 | Option Exercise | 10,000 | $52.27 | $522,700.00 | 45% 22.2K to 32.2K | |
13-May-24 5:32 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 09-May-24 | Option Sale | 10,000 | $83.04 | $830,449.00 | (31%) 32.2K to 22.2K | |
29-Feb-24 6:50 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 27-Feb-24 | Grant | 7,208 | -- | -- | 48% 15.0K to 22.2K | |
16-Feb-24 8:10 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-24 | Payment of Exercise | 593 | $74.65 | $44,267.40 | (4%) 15.59K to 15.0K | |
04-Jan-24 4:07 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 29-Dec-23 | Acquisition (other) | 179 | $60.71 | $10,866.60 | 1% 15.41K to 15.59K | |
14-Aug-23 4:20 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Aug-23 | Payment of Exercise | 897 | $68.73 | $61,650.80 | (6%) 16.31K to 15.41K | |
28-Mar-23 5:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 24-Mar-23 | Sale | 300 | $69.92 | $20,977.30 | (2%) 16.61K to 16.31K | |
27-Feb-23 8:51 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 23-Feb-23 | Grant | 5,668 | -- | -- | 52% 10.94K to 16.61K | |
01-Dec-22 9:39 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Nov-22 | Payment of Exercise | 1,073 | $72.90 | $78,221.70 | (9%) 12.01K to 10.94K |